ZEB1 and endometrial cancer: Tamoxifen, which is known to cause endometrial cancer, has also been shown to contribute to the EMT of endometrial cancer through its interaction with a family of miRNA, miR-200s, that can inhibit TGFβ-induced EMT by repressing ZEB1/2 (26, 34).